Difference in Acquired Radioresistance Induction Between Repeated Photon and Particle Irradiation
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference94 articles.
1. Hypofractinated stereoptactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japnese multi-institutional study;Ohnishi;J Thorac Oncol.,2007
2. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients;Sanuki;Acta Oncol.,2014
3. Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes;Freeman;Radio Oncol.,2011
4. Clinical outcomes of stereotactic body radiotherapy for patients with stage I small-cell lung cancer: analysis of a subset of the Japanese radiological society multi-institutional SBRT study group database;Shioyama;Technol Cancer Res Treat.,2018
5. Clinical outcomes in early-stage NSCLC treated with stereotactic body radiotherapy versus surgical resection;Kastelijn;Anticancer Res.,2015
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapy;Life Science Alliance;2024-02-05
2. Fractionated radiation exposure enhances the DNA repair capacity to acquire radioresistance in HCT8 human colorectal cancer cells;International Journal of Radiation Research;2023-10-01
3. Carbon–Ion Radiation Therapy for Unresectable Locally Recurrent Colorectal Cancer: A Promising Curative Treatment for Both Radiation Therapy–Naïve Cases and Reirradiation Cases;International Journal of Radiation Oncology*Biology*Physics;2023-09
4. Repeated Carbon-Ion Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma;International Journal of Radiation Oncology*Biology*Physics;2023-08
5. CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks;Molecular Cancer;2023-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3